Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000245759 | SCV000319124 | uncertain significance | Cardiovascular phenotype | 2013-11-22 | criteria provided, single submitter | clinical testing | The p.G2003R variant (also known as c.6007G>A) is located in coding exon 46 of the CACNA1C gene. This alteration results from a G to A substitution at nucleotide position 6007. The glycine at codon 2003 is replaced by arginine, an amino acid with dissimilar properties. ​This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. This amino acid position is poorly conserved on sequence alignment.This variant is predicted to be benign by PolyPhen and tolerated by SIFT in silico analyses. Since supporting evidence is limited at this time, the clinical significance of p.G2003R remains unclear. |
Invitae | RCV001854973 | SCV002303817 | likely benign | Long QT syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing |